JP2023522056A5 - - Google Patents
Info
- Publication number
- JP2023522056A5 JP2023522056A5 JP2022562978A JP2022562978A JP2023522056A5 JP 2023522056 A5 JP2023522056 A5 JP 2023522056A5 JP 2022562978 A JP2022562978 A JP 2022562978A JP 2022562978 A JP2022562978 A JP 2022562978A JP 2023522056 A5 JP2023522056 A5 JP 2023522056A5
- Authority
- JP
- Japan
- Prior art keywords
- liraglutide
- lenalidomide
- azacitidine
- active agent
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005593.5 | 2020-04-17 | ||
| GBGB2005593.5A GB202005593D0 (en) | 2020-04-17 | 2020-04-17 | New composition |
| PCT/GB2021/050913 WO2021209762A1 (en) | 2020-04-17 | 2021-04-16 | Injectable oil-based pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522056A JP2023522056A (ja) | 2023-05-26 |
| JP2023522056A5 true JP2023522056A5 (enExample) | 2024-04-19 |
Family
ID=70860026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562978A Pending JP2023522056A (ja) | 2020-04-17 | 2021-04-16 | 新しい注射用油性医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230157968A1 (enExample) |
| EP (1) | EP4135672A1 (enExample) |
| JP (1) | JP2023522056A (enExample) |
| KR (1) | KR20230004568A (enExample) |
| CN (1) | CN116075295A (enExample) |
| AU (1) | AU2021256075A1 (enExample) |
| CA (1) | CA3179556A1 (enExample) |
| GB (1) | GB202005593D0 (enExample) |
| WO (1) | WO2021209762A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024546476A (ja) * | 2021-12-08 | 2024-12-24 | ナネクサ・アクチボラグ | 新たな注射用併用製剤 |
| GB2619556A (en) * | 2022-06-10 | 2023-12-13 | Nanexa Ab | New process |
| JP2026500290A (ja) * | 2022-12-15 | 2026-01-06 | ナネクサ・アクチボラグ | グルカゴン様ペプチド－１受容体アゴニストを含む新規医薬組成物 |
| GB202218958D0 (en) | 2022-12-15 | 2023-02-01 | Nanexa Ab | New pharmaceutical composition |
| CN117844877B (zh) * | 2024-01-14 | 2024-09-06 | 宿州市东凯医药科技有限公司 | 一种通过生物酶制备普瑞巴林的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006080895A1 (en) | 2005-01-20 | 2006-08-03 | Agency For Science, Technology And Research | Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling |
| SI2341905T2 (sl) * | 2008-09-04 | 2024-02-29 | Amylin Pharmaceuticals, Llc | Formulacije s podaljšanim sproščanjem z uporabo brezvodnih nosilcev |
| PL3003286T3 (pl) * | 2013-05-24 | 2022-10-10 | Nanexa Ab | Sposób wytwarzania stałych nanocząstek z nieorganiczną powłoką i ich zastosowanie |
-
2020
- 2020-04-17 GB GBGB2005593.5A patent/GB202005593D0/en not_active Ceased
-
2021
- 2021-04-16 WO PCT/GB2021/050913 patent/WO2021209762A1/en not_active Ceased
- 2021-04-16 CA CA3179556A patent/CA3179556A1/en active Pending
- 2021-04-16 JP JP2022562978A patent/JP2023522056A/ja active Pending
- 2021-04-16 EP EP21721971.6A patent/EP4135672A1/en active Pending
- 2021-04-16 AU AU2021256075A patent/AU2021256075A1/en active Pending
- 2021-04-16 US US17/919,415 patent/US20230157968A1/en active Pending
- 2021-04-16 CN CN202180041014.6A patent/CN116075295A/zh active Pending
- 2021-04-16 KR KR1020227038860A patent/KR20230004568A/ko active Pending